GridAI Technologies (GRDX) Net Income (2015 - 2026)
GridAI Technologies' (GRDX) quarterly Net Income came in at -$13.0 million in Q2 2026, down 1206.29% on a YoY basis from $1.2 million in Q2 2025, and down 268.2% quarter-over-quarter from -$3.5 million in Q4 2025.
Analysis
GridAI Technologies (GRDX) Net Income (2015 - 2026) Analysis & Trends
GridAI Technologies (GRDX) has reported Net Income for 12 consecutive years, with -$13.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Income fell 1206.29% year-over-year to -$13.0 million; the trailing twelve-month figure through Jun 2026 stood at -$18.7 million (down 204.06% YoY), and the FY2025 full-year result was -$6.6 million, up 63.71% from the prior year.
- Net Income slipped to -$13.0 million in Q2 2026 per GRDX's latest filing, from -$3.5 million in the prior quarter.
- Across five years, Net Income topped out at $5.8 million in Q1 2024 and bottomed at -$13.0 million in Q2 2026.
- Historically, Net Income has averaged -$3.3 million across 5 years, with a median of -$3.4 million in 2023.
- The sharpest annual moves came in 2024 and 2026: Net Income jumped 241.51% in 2024, then sank 1206.29% in 2026.
- Over 5 years, Net Income stood at -$2.3 million in 2022, then plunged by 80.84% to -$4.1 million in 2023, then soared by 60.4% to -$1.6 million in 2024, then sank by 116.79% to -$3.5 million in 2025, then sank by 268.2% to -$13.0 million in 2026.
- According to Business Quant data, Net Income over the past three periods registered -$13.0 million, -$3.5 million, and -$1.2 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 2.38 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -10.50 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 1.10 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 1.30 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 601.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -782.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 164.49 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 97.50 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -290.61 Mn |
| 10 | GridAI Technologies | 19.07 Mn | 19.07 Mn | -36,514.00 | -13.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -13.04 Mn |
| Dec 31, 2025 | -3.54 Mn |
| Sep 30, 2025 | -1.15 Mn |
| Jun 30, 2025 | -998,271.00 |
| Mar 31, 2025 | -948,105.00 |
| Dec 31, 2024 | -1.63 Mn |
| Sep 30, 2024 | -2.58 Mn |
| Jun 30, 2024 | -8.81 Mn |
| Mar 31, 2024 | 5.76 Mn |
| Dec 31, 2023 | -4.13 Mn |
| Sep 30, 2023 | -3.43 Mn |
| Jun 30, 2023 | -4.19 Mn |
| Mar 31, 2023 | -4.07 Mn |
| Dec 31, 2022 | -2.28 Mn |
| Sep 30, 2022 | 4.39 Mn |
| Jun 30, 2022 | -5.41 Mn |
| Mar 31, 2022 | -9.39 Mn |
| Dec 31, 2021 | -11.17 Mn |
| Sep 30, 2021 | -30.40 Mn |
| Jun 30, 2021 | -9.28 Mn |